期刊文献+

A2780-cp卵巢癌细胞株NOD scid小鼠原位成瘤模型的建立 被引量:1

Effectively establishing ovarian carcinoma model in situ by injection of A2780-cp cells
下载PDF
导出
摘要 目的:建立A2780-cp卵巢癌细胞株的NOD scid小鼠原位成瘤模型,为卵巢癌的进一步研究提供参考载体.方法:体外培养A2780-cp卵巢癌细胞,制成细胞密度为5×10^6/mL的单细胞悬液,原位种植:取20μL注入小鼠卵巢皮下;皮下种植:癌细胞悬液0.1mL注入小鼠右侧腋下皮下.肉眼观察并通过核磁共振成像(MRI)测量小鼠成瘤情况,切片光镜观察瘤体组织结构.结果:NOD scid小鼠原位及皮下均能成瘤,MRI及组织病理切片结果均提示种瘤成功.结论:经卵巢原位注射A2780-cp细胞能有效地建立小鼠卵巢癌原位成瘤模型.MRI能无创性检测小鼠卵巢癌成瘤情况. Aim: To establish A2780-cp ovarian cancer cell lines in situ tumor model on NOD scid mice, in order to provide the reference for the further study of the carrier for ovarian cancer. Methods Cultivation, collection and PBS wash cells and made into cell density of 5 × 10^6/mL single cell suspen-sion in vitro. In situ plant: took 20 μL cell suspension injecting in NOD scid mice ovarian subcutaneous. Subcutaneous planting : 0. 1 mL cell suspension injected in right axillary subcutaneous of the mice. Ob-servation and through MRI measured tumor in mice, and used the HE staining to observe tumors present organization structure slice. Results: Both in situ and subcutaneous, SCID NOD mice can be discovered tumour mass. MRI and histopathology Can be used to confirm this conclusion. Conclusion : Ovarian carci-noma in SCID NOD mice can be effectively established by ovarian in situ injection of A2780-cp cells. MRI can be used to detect the tumor of ovarian cancer in mice.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2016年第6期488-491,496,共5页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 吴阶平医学科学研究基金项目(1993)
关键词 卵巢癌 NOD SCID小鼠 小鼠模型 原位肿瘤移植 磁共振成像 ovarian cancer NOD scid mice mouse model in situ tumor transplantation magnetic resonance imaging
  • 相关文献

参考文献4

二级参考文献40

  • 1全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 2Jemal A,Tiwari RC,Murray T,et al. Cancer statistics, 2004 [J]. Ca Cancer J Clin,2004,54(1): 8-29.
  • 3International Agency for Research on Cancer. GLOBO- CAN 2008. [EB/OI,]. http://www-dep.iarc.fr,2013-02-22.
  • 4Curado MPEB,Shin HR,Storm H,et al. Cancer Incidence in Five Continents,Vol. IX [M]. Lyon:IARC Scientific Publica- tions,2008.
  • 5Bray F,Parkin DM. Evaluation of data quality in the can- cer regist': Principles and methods. Part | : Comparabil- ity,validity and timeliness [J]. Eur J Cancer,2009,45(5): 747-755.
  • 6Felay J,Burkhard C,Whelan S,et al. Check and Conver- sion Programs for Cancer Registries.(IARC/IACR tools for Cancer Registries) IARC Technical Report No.42 [M]. 1,yon: IARC ,2005.
  • 7赫捷,赵平,陈万青.2011年中国肿瘤登记年报.北京:军事医学科学出版社,2012.
  • 8Rochet N,Kieser M,Sterzing F. Phase Ⅱ study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in paticnts with advanced ovarian cancer stage FIGO Ⅲ-the OVAR-IMRT-02 Study[J].BMC Cancer,2011.41.doi:10.1186/1471-2407-11-41.
  • 9Connolly DC. Animal models of ovarian cancer[J].Cancer Treatment and Research,2009.353-391.
  • 10Seo HW,Rengaraj D,Choi JW. The expression profile of apoptosis-related genes in the chicken as a human epithdial ovarian cancer model[J].Oncology Reports,2011,(01):49-56.

共引文献66

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部